Providence Swedish Cancer Institute — Seattle, Washington

Providence Swedish Cancer Institute is a clinical research site located in Seattle, Washington, United States 98104.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Providence Swedish Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.

Sponsors: PeproMene Bio, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Providence Swedish Cancer Institute?

Providence Swedish Cancer Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Providence Swedish Cancer Institute conducted?

Providence Swedish Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.

Is Providence Swedish Cancer Institute accredited by Crixeo Health?

Providence Swedish Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Providence Swedish Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.